|
|
|
|
|
Intermediate of Cefozopran(CAS:197897-11-3) |
|
1-[((7R)-7-amino-4-carboxy-3,4-didehydrochepham-3-yl)methyl]-1H-imidazo[1,2-b] pyridazin-4-ium Iodide |
|
197897-11-3 |
|
Intermediate of Cefozopran |
|
Cefozopran HCl and the Intermediates:
(1) Imidazo[1,2-b]pyridazine CAS: 766-55-2 Standard: Enterprise Standard Package: 20kg/25kg
(2) 1-[((7R)-7-amino-4-carboxy-3,4-didehydrochepham-3-yl)methyl]-1H-imidazo[1,2-b] pyridazin-4-ium Iodide CAS: 197897-11-3 Standard: Enterprise Standard Package: 20kg/25kg
(3) (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetic acid CAS: 72217-12-0 Standard: Enterprise Standard Package: 20kg/25kg
(4) S-2-benzothiazolyl (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino thioacetate CAS: 89604-91-1 Standard: Enterprise Standard Package: 20kg/25kg
(5) Cefozopran CAS : 113359-04-9 Standard: Enterprise Standard Package: 20kg/25kg
(6) Cefozopran hydrochloride CAS :113981-44-5 Standard: JP15 Package: 5kg/10kg
(7) Mixture of Cefozopran HCl and Sodium carbonate Standard: Enterprise Standard Appearance: White to pale yellow, crystals or crystalline powder Use: to produce Cefozopran HCl for injection.
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|